Citigroup
ZSAN

Citigroup’s Zosano Pharma Corporation ZSAN Stock Holding History

Citigroup’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,563
Closed -$28K – 6920
2022
Q1 		$28K Buy
+3,563
New +$39.2K ﹤0.01% 4992

Other funds holding ZSAN

CDIA
Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Citigroup's ZSAN Position: Q2 2022 in Review

Citigroup sold out of Zosano Pharma Corporation (ZSAN) in Q2 2022, closing a stake of 3,563 shares — an estimated $28K sold.

Citigroup first reported a position in ZSAN in Q1 2022 and held it in 1 quarter. The position peaked at $28K in Q1 2022. 3 funds tracked by Wall St. Rank hold ZSAN as of Q2 2022.

  • Citigroup reported no remaining Zosano Pharma Corporation position as of Q2 2022 after selling out during the quarter.
  • Citigroup sold 3,563 Zosano Pharma Corporation shares in Q2 2022, an estimated $28K.
  • Citigroup first reported a position in Zosano Pharma Corporation in Q1 2022 and held it in 1 quarter.
  • Citigroup's Zosano Pharma Corporation position peaked at $28K in Q1 2022.
  • 3 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2022.

Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.